[Table/Fig-1]:
Clinical characteristic | Group A | Group B |
---|---|---|
No of patients | 30 | 30 |
Male | 20 | 18 |
Female | 10 | 12 |
Mean follow up period | 6 months | 6 months |
Range | 3-8 months | 4-9 months |
Pretreatment AEC | 532 μg/l | 578 μg/l |
Post-treatment AEC | 482 μg/l | 438 μg/l |
No of patients with normalized AEC | 0 | 0 |
Pretreatment IgE | 886.20 IU/ml | 935 IU/ml |
Post-treatment IgE | 620.00 IU/ml | 570 IU/ml |
No of patients with normalized IgE | 18 | 20 |
Pretreatment mean SNOT score | 52 .5 | 55.7 |
Post-treatment mean SNOT score | 34.3 | 29.5 |
Pretreatment Kupferberg’s endoscopic grading (Grade 4) | 100% | 100% |
Post treatment Kupferberg’s endoscopic grading (Grade 0) | 7(23.33%) | 8(26.66%) |
Recurrence of nasal polyp | 9(32.14%) | 7(25.92%) |